Here are five takeaways from the study.
1. Researchers identified consistent relationships between depression/anxiety and subjectively measured components of the 28-Joint Disease Activity Score.
2. Patients who presented symptoms of depression/anxiety had decreased odds of attaining rheumatoid arthritis remission at two years.
3. Researchers found baseline depression/anxiety was linked with a 50 percent reduced prednisone treatment response in this patient population.
4. Lead researcher, Faith Matcham, stated the findings do not indicate there is a casual relationship between mental health and RA outcomes, but a bidirectional relationship. She writes, “Our results suggest that symptoms of depression/anxiety may reduce the body’s ability to respond to glucocorticoid treatment.”
5. The data suggests patients may have a better treatment response if they are provided with enhanced management of mental disorders. Researchers call for more studies to determine if this hypothesis is correct.
More articles on orthopedics:
OrthoIndy welcomes 2 orthopedic surgeons — 5 key facts
New UVA orthopedics clinic to open in Culpeper: 4 notes
Dr. Mark Seeley joins Geisinger’s Orthopedic Institute: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
